imiquimod has been researched along with Atheroma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Colato, C; Giannetti, L; Girolomoni, G; Maurelli, M | 1 |
Bult, H; De Meyer, GR; De Meyer, I; Martinet, W; Schrijvers, DM; Timmermans, JP | 1 |
De Meyer, GR; De Meyer, I; Martinet, W; Schrijvers, DM; Timmermans, JP; Verheye, S | 1 |
1 review(s) available for imiquimod and Atheroma
Article | Year |
---|---|
Drug-induced macrophage autophagy in atherosclerosis: for better or worse?
Topics: Aminoquinolines; Animals; Autophagy; Cytokines; Everolimus; Humans; Imiquimod; Macrophages; Mice; Plaque, Atherosclerotic; Sirolimus; Toll-Like Receptor 7; TOR Serine-Threonine Kinases | 2013 |
2 other study(ies) available for imiquimod and Atheroma
Article | Year |
---|---|
Lymphoplasmacytic plaque effectively treated with imiquimod.
Topics: Aminoquinolines; Humans; Imiquimod; Plaque, Atherosclerotic; Skin Abnormalities; Skin Neoplasms | 2021 |
Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Autophagy; Blotting, Western; Cytokines; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Imiquimod; Immunohistochemistry; Inflammation; Inflammation Mediators; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; NF-kappa B; Plaque, Atherosclerotic; Rabbits; Time Factors; Toll-Like Receptor 7; U937 Cells | 2012 |